{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:19:21Z","timestamp":1779884361318,"version":"3.53.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11897-024-00664-y","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T06:01:47Z","timestamp":1714024907000},"page":"186-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Economic Considerations of Cardiovascular Implantable Electronic Devices for The Treatment of Heart Failure"],"prefix":"10.1007","volume":"21","author":[{"given":"Christian","family":"Elsner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Bettin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Tilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"H\u00e4ckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"664_CR1","first-page":"1789","volume":"392","author":"GBD","year":"2017","unstructured":"GBD. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2017;392:1789\u2013858.","journal-title":"Lancet"},{"key":"664_CR2","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/eurheartj\/ehm102","volume":"28","author":"FD Hobbs","year":"2007","unstructured":"Hobbs FD, Roalfe AK, Davis RC, Davies MK, Hare R. the Midlands Research Practices Consortium (MidReC). Prognosis of all-cause heart failure and borderline left ventricu- lar systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J. 2007;28:1128\u201334.","journal-title":"Eur Heart J"},{"key":"664_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ijcard.2013.12.028","volume":"171","author":"C Cook","year":"2014","unstructured":"Cook C, Cole G, Asaria P, Jabbour R, Francis DP. The annual global economic burden of heart failure. Int J Cardiol. 2014;171:368\u201376.","journal-title":"Int J Cardiol"},{"key":"664_CR4","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.amjcard.2015.07.018","volume":"116","author":"GA Nichols","year":"2015","unstructured":"Nichols GA, Reynolds K, Kimes TM, Rosales AG, Chan WW. Comparison of risk of re- hospitalization, all-cause mortality, and medical care resource utilization in patients with heart failure and preserved versus reduced ejection fraction. Am J Cardiol. 2015;116:1088\u201392.","journal-title":"Am J Cardiol"},{"key":"664_CR5","doi-asserted-by":"crossref","unstructured":"Maggioni AP, Dahlstr\u00f6m U, Filippatos G, Chioncel O, Leiro MC, Drozdz J, ... Heart Failure Association of the ESC (HFA) (2010) EURObservational research programme: the heart failure pilot survey (ESC\u2010HF Pilot). Europe J Heart Fail 12(10):1076\u20131084","DOI":"10.1093\/eurjhf\/hfq154"},{"issue":"9","key":"664_CR6","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","volume":"93","author":"A Mosterd","year":"2007","unstructured":"Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93(9):1137\u201346. https:\/\/doi.org\/10.1136\/hrt.2003.025270.","journal-title":"Heart"},{"issue":"1","key":"664_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","volume":"3","author":"G Savarese","year":"2017","unstructured":"Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7\u201311. https:\/\/doi.org\/10.15420\/cfr.2016:25:2.","journal-title":"Card Fail Rev."},{"issue":"27","key":"664_CR8","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128.","journal-title":"Eur Heart J."},{"issue":"2","key":"664_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ehf2.12005","volume":"1","author":"MR Cowie","year":"2014","unstructured":"Cowie MR, Anker SD, Cleland JGF, et al. Improving care for patients with acute heart failure: before, during and after hospitalization. ESC Heart Fail. 2014;1(2):110\u201345. https:\/\/doi.org\/10.1002\/ehf2.12005.","journal-title":"ESC Heart Fail"},{"issue":"4","key":"664_CR10","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133(4):e38\u2013360. https:\/\/doi.org\/10.1161\/CIR.0000000000000350.","journal-title":"Circulation"},{"issue":"16","key":"664_CR11","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147\u2013239. https:\/\/doi.org\/10.1016\/j.jacc.2013.05.019.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"664_CR12","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJV McMurray","year":"2012","unstructured":"McMurray JJV, Adamopoulos S, Anker SD, et al. Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787\u2013847. https:\/\/doi.org\/10.1093\/eurheartj\/ehs104.","journal-title":"Eur Heart J."},{"issue":"5","key":"664_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/s0195-668x(02)00823-0","volume":"24","author":"M Komajda","year":"2003","unstructured":"Komajda M, Follath F, Swedberg K, et al. The EuroHeart Failure Survey programme\u2013a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J. 2003;24(5):464\u201374. https:\/\/doi.org\/10.1016\/s0195-668x(02)00823-0.","journal-title":"Eur Heart J."},{"key":"664_CR14","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368.","journal-title":"Eur Heart J"},{"key":"664_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2147\/CLEP.S170873","volume":"11","author":"K Lindmark","year":"2019","unstructured":"Lindmark K, Boman K, Olofsson M, T\u00f6rnblom M, Levine A, Castelo-Branco A, Schlienger R, Bruce Wirta S, St\u00e5lhammar J, Wikstr\u00f6m G. Epidemiology of heart failure and trends in diagnostic work-up: a retrospective, population-based cohort study in Sweden. Clin Epidemiol. 2019;11:231\u201344.","journal-title":"Clin Epidemiol"},{"key":"664_CR16","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.hlc.2018.01.009","volume":"27","author":"MS Al-Omary","year":"2018","unstructured":"Al-Omary MS, Davies AJ, Evans TJ, Bastian B, Fletcher PJ, Attia J, Boyle AJ. Mortality and readmission following hospitalisation for heart failure in Australia: a systematic review and meta-analysis. Heart Lung Circ. 2018;27:917\u201327.","journal-title":"Heart Lung Circ"},{"issue":"17","key":"664_CR17","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2022","unstructured":"Savarese G. Peter Moritz Becher, Lars H Lund, Petar Seferovic, Giuseppe M C Rosano, Andrew J S Coats, Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2022;118(17):3272\u201387. https:\/\/doi.org\/10.1093\/cvr\/cvac013.","journal-title":"Cardiovasc Res"},{"key":"664_CR18","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1093\/eurheartj\/ehz773","volume":"41","author":"S Barra","year":"2020","unstructured":"Barra S, Providencia R, Narayanan K, Boveda S, Duehmke R, Garcia R, Leyva F, Roger V, Jouven X, Agarwal S, Levy WC, Marijon E. Time trends in sudden cardiac death risk in heart failure patients with cardiac resynchronization therapy: a systematic review. Eur Heart J. 2020;41:1976\u201386.","journal-title":"Eur Heart J"},{"issue":"2","key":"664_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1017\/S0266462305050221","volume":"21","author":"M Drummond","year":"2005","unstructured":"Drummond M, Manca A, Sculpher M. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care. 2005;21(2):165\u201371. https:\/\/doi.org\/10.1017\/S0266462305050221.","journal-title":"Int J Technol Assess Health Care"},{"key":"664_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2020.1746316","author":"D Shah","year":"2020","unstructured":"Shah D, et al. Cost-effectiveness analysis of implantable cardiac devices in patients with systolic heart failure: A US perspective using real world data. J Med Econ. 2020. https:\/\/doi.org\/10.1080\/13696998.2020.1746316.","journal-title":"J Med Econ"},{"issue":"32","key":"664_CR21","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.jacc.2012.12.022","volume":"61","author":"G Banka","year":"2013","unstructured":"Banka G, Heidenreich PA, Fonarow GC. Incremental cost-effectiveness of guideline-directed medical therapies for heart failure. J Am Coll Cardiol. 2013;61(32):1440.","journal-title":"J Am Coll Cardiol."},{"key":"664_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ahj.2020.06.002","volume":"227","author":"P Joseph","year":"2020","unstructured":"Joseph P, Dokainish H, McCready T, Budaj A, Roy A, Ertl G, Gomez-Mesa JE, Leong D, Ezekowitz J, Hage C, Lanas F, Maggioni AP, Sliwa K, Zhu J, Rouleau J, Balasubramanian K, Yusuf S, Investigators GC. A multinational registry to study the characteristics and outcomes of heart failure patients: the global congestive heart failure (G-CHF) registry. Am Heart J. 2020;227:56\u201363.","journal-title":"Am Heart J"},{"key":"664_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13690-021-00729-7","volume":"79","author":"E Kocot","year":"2021","unstructured":"Kocot E, Kotarba P, Dubas-Jak\u00f3bczyk K. The application of the QALY measure in the assessment of the effects of health interventions on an older population: a systematic scoping review. Arch Public Health. 2021;79:201. https:\/\/doi.org\/10.1186\/s13690-021-00729-7.","journal-title":"Arch Public Health"},{"issue":"7","key":"664_CR24","doi-asserted-by":"publisher","first-page":"205031211985698","DOI":"10.1177\/2050312119856986.PMID:31217971;PMCID:PMC6563399","volume":"12","author":"BN Patenaude","year":"2019","unstructured":"Patenaude BN, B\u00e4rnighausen T. Quality-adjusted life year weights and treatment bias: Theory and evidence from cognitive interviews. SAGE Open Med. 2019;12(7):2050312119856986. https:\/\/doi.org\/10.1177\/2050312119856986.PMID:31217971;PMCID:PMC6563399.","journal-title":"SAGE Open Med"},{"issue":"9","key":"664_CR25","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jacc.2021.06.040","volume":"78","author":"M Fudim","year":"2021","unstructured":"Fudim M, Abraham W, von Bardeleben R, et al. Device Therapy in Chronic Heart Failure. J Am Coll Cardiol. 2021;78(9):931\u201356. https:\/\/doi.org\/10.1016\/j.jacc.2021.06.040.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"664_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/HCO.0000000000001026","volume":"38","author":"JA Brooksbank","year":"2023","unstructured":"Brooksbank JA, Albert C. Device-based therapies for decompensated heart failure. Curr Opin Cardiol. 2023;38(2):116\u201323. https:\/\/doi.org\/10.1097\/HCO.0000000000001026. (Epub 2023 Jan 11 PMID: 36718621).","journal-title":"Curr Opin Cardiol"},{"key":"664_CR27","doi-asserted-by":"publisher","unstructured":"Oliveira Cardoso Cristiano, Elgalad Abdelmotagaly, Li Ke, Perin Emerson C. Device-based therapy for decompensated heart failure: An updated review of devices in development based on the DRI2P2S classification in Frontiers in Cardiovascular Medicine Vol. 9 2022 https:\/\/doi.org\/10.3389\/fcvm.2022.962839.","DOI":"10.3389\/fcvm.2022.962839"},{"key":"664_CR28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00392-019-01447-5","volume":"108","author":"JC Geller","year":"2019","unstructured":"Geller JC, Lewalter T, Bruun NE, et al. Implant-based multi-parameter telemonitoring of patients with heart failure and a defibrillator with vs. without cardiac resynchronization therapy option: a subanalysis of the IN-TIME trial. Clin Res Cardiol. 2019;108:1117\u201327. https:\/\/doi.org\/10.1007\/s00392-019-01447-5.","journal-title":"Clin Res Cardiol"},{"key":"664_CR29","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3390\/s21030887","volume":"21","author":"JF Veenis","year":"2021","unstructured":"Veenis JF, Radhoe SP, Hooijmans P, Brugts JJ. Remote monitoring in chronic heart failure patients: is non-invasive remote monitoring the way to go? Sensors (Basel). 2021;21:887. https:\/\/doi.org\/10.3390\/s21030887.","journal-title":"Sensors (Basel)"},{"key":"664_CR30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1177\/1357633X19832713","volume":"26","author":"SL Cichosz","year":"2020","unstructured":"Cichosz SL, Udsen FW, Hejlesen O. The impact of telehealth care on health-related quality of life of patients with heart failure: results from the Danish TeleCare North heart failure trial. J Telemed Telecare. 2020;26:452\u201361. https:\/\/doi.org\/10.1177\/1357633X19832713.","journal-title":"J Telemed Telecare"},{"key":"664_CR31","doi-asserted-by":"publisher","unstructured":"Niels T B Scholte, Muhammed T G\u00fcrg\u00f6ze, Dilan Aydin, Dominic A M J Theuns, Olivier C Manintveld, Eelko Ronner, Eric Boersma, Rudolf A de Boer, Robert M A van der Boon, Jasper J Brugts, Telemonitoring for heart failure: a meta-analysis, Eur Heart J., Volume 44, Issue 31, 14 2023, Pages 2911\u20132926, https:\/\/doi.org\/10.1093\/eurheartj\/ehad280.","DOI":"10.1093\/eurheartj\/ehad280"},{"key":"664_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12962-021-00285-5","volume":"19","author":"A Teimourizad","year":"2021","unstructured":"Teimourizad A, Rezapour A, Sadeghian S, et al. Cost-effectiveness of cardiac resynchronization therapy plus an implantable cardioverter-defibrillator in patients with heart failure: a systematic review. Cost Eff Resour Alloc. 2021;19:31. https:\/\/doi.org\/10.1186\/s12962-021-00285-5.","journal-title":"Cost Eff Resour Alloc"},{"issue":"3","key":"664_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ijcard.2011.06.046","volume":"163","author":"EG Bertoldi","year":"2013","unstructured":"Bertoldi EG, et al. Cost-effectiveness of cardiac resynchronization therapy in patients with heart failure: the perspective of a middle-income country\u2019s public health system. Int J Cardiol. 2013;163(3):309\u201315.","journal-title":"Int J Cardiol"},{"key":"664_CR34","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1136\/heartjnl-2015-308883","volume":"102","author":"S Mealing","year":"2016","unstructured":"Mealing S, Woods B, Hawkins N, et al. Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure. Heart. 2016;102:1742\u20139.","journal-title":"Heart"},{"key":"664_CR35","doi-asserted-by":"publisher","unstructured":"Tomini F, Prinzen F, van Asselt AD. A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure. Eur J Health Econ. 2016 Dec;17(9):1159\u20131172. https:\/\/doi.org\/10.1007\/s10198-015-0752-3.","DOI":"10.1007\/s10198-015-0752-3"},{"issue":"12","key":"664_CR36","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1080\/13696998.2020.1833893","volume":"23","author":"C Martignani","year":"2020","unstructured":"Martignani C, Massaro G, Diemberger I, Ziacchi M, Angeletti A, Gali\u00e8 N, Biffi M. Cost-effectiveness of cardiac resynchronization therapy. J Med Econ. 2020;23(12):1375\u20138. https:\/\/doi.org\/10.1080\/13696998.2020.1833893.","journal-title":"J Med Econ"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-024-00664-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11897-024-00664-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-024-00664-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:04:50Z","timestamp":1715591090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11897-024-00664-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1007\/s11897-024-00664-y","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"assertion":[{"value":"15 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Roland Tilz is a consultant for Boston Scientific, Biotronik, Biosense Webster, Abbott Medical, he received speaker`s honoraria from Boston Scientific, Biotronik, Biosense Webster, Abbott Medical, Lifetech and research grants from Abbott, Biosense Webster, Lifetech.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors. All studies cited in this article fulfilled the above guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement"}},{"value":"This article did not process any data that needs an informed consent, nor was new data generated, which needs an additional ethics confirmation. All studies cited in this article fulfilled the above guidelines.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}}]}}